Effect of Different Anti-Aβ Antibodies on Aβ Fibrillogenesis as Assessed by Atomic Force Microscopy

Journal of Molecular Biology

Volumn 335, Issue 4, 2004, Pages 997-1006

  Legleiter, Justin ^a   Czilli, Dan L ^b   Gitter, Bruce ^b   DeMattos, Ronald B ^b   Holtzman, David M ^c   Kowalewski, Tomasz ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AFM; Alzheimer's disease; Amyloid ; Anti A antibodies; Fibrillogenesis

Indexed keywords

AMINO ACID DERIVATIVE; AMINO ACID[1-5]; AMINO ACID[13-28]; AMYLOID BETA ANTIBODY; AMYLOID BETA PROTEIN[1-42]; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M266 2; MONOCLONAL ANTIBODY M3D6; THIOFLAVINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; AQUEOUS SOLUTION; ARTICLE; ATOMIC FORCE MICROSCOPY; COMPARATIVE STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME SPECIFICITY; EXPERIMENTAL TEST; FIBER; FLUORESCENCE; INCUBATION TIME; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; RELIABILITY;

EID: 0345862278     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.11.019     Document Type: Article

References (32)

1. Selkoe D.J. Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease. Trends Neurosci. 16:1993;403-409.
2. Esch F., Keim P.S., Beattie E.C., Blacher R.W., Culwell A.R. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 248:1990;1122-1128.
3. Jarrett J.T., Berger E.P., Lansbury P.T. The carboxy terminus of beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697.
4. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8:1998;101-106.
5. Smith M.A. Alzheimer's disease. Int. Rev. Neurobiol. 42:1998;1-54.
6. Cai X.D., Golde T.E., Younkin S.G. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science. 259:1993;514-516.
7. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81:2001;741-766.
8. George-Hyslop P. St. Alzhemier's disease. Neurobiol. Dis. 7:2000;546-548.
9. Miravalle L., Tokuda T., Chiarle R., Giaccone G., Bugiani O., Tagliavini F., et al. Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J. Biol. Chem. 275:2000;27110-27116.
10. Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., Forsell C., et al. The Arctic APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nature Neurosci. 4:2001;887-893.
11. Monro O.R., Mackic J.B., Yamada S., Segal M.B., Ghiso J., Maurer C., et al. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol. Aging. 23:2002;405-412.
12. Wisniewski T., Ghiso J., Frangione B. Biology of A beta amyloid in Alzheimer's disease. Neurobiol. Dis. 4:1997;313-328.
13. 1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nature Med. 6:2000;143-150.
14. (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J. Clin. Invest. 106:2000;1489-1499.
15. Ghersi-Egea J.-F., Gorevic P.D., Ghiso J., Frangione B., Patlak C.S., Fensternacher J.D. Fate of cerebrospinal fluid-borne amyloid β-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J. Neurochem. 67:1996;880-883.
16. Frenkel D., Katz O., Solomon B. Immunization against Alzheimer's β-amyloid plaques via EFRH phage administration. Proc. Natl Acad. Sci. USA. 97:2000;11455-11459.
17. Frenkel D., Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl Acad. Sci. USA. 99:2002;5675-5679.
18. Solomon B., Koppel R., Hanan E., Katzav T. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer β-amyloid peptide. Proc. Natl Acad. Sci. USA. 93:1996;452-455.
19. Solomon B., Koppel R., Frankel D., Hanan-Aharon E. Disaggregation of Alzheimer β-amyloid by site-directed mAb. Proc. Natl Acad. Sci. USA. 94:1997;4109-4112.
20. DeMattos R.B., Bales K.R., Cummins D.J., Dodart J.-C., Paul S.M., Holtzman D.M. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA. 98:2001;8850-8855.
21. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., Holtzman D.M. Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science. 295:2002;2264-2267.
22. Bard F., Cannon C., Barbour R., Burke R.-L., Games D., Grajeda H., et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Med. 6:2000;916-919.
23. (1-40) amyloid fibrils. Exp. Neurol. 158:1999;437-443.
24. Blackley H.K.L., Sanders G.H.W., Davies M.C., Roberts C.J., Tendler S.J.B., Wilkinson M.J. In situ atomic force microscopy study of β-amyloid fibrillization. J. Mol. Biol. 298:2000;833-840.
25. Goldsbury C., Kistler J., Aebi U., Arvinte T., Cooper G.J.S. Watching amyloid fibrils grow by time-lapse atomic force microscopy. J. Mol. Biol. 285:1999;33-39.
26. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Atomic force microscopy imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein. Chem. Biol. 4:1997;951-959.
27. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol. 4:1997;119-125.
28. Kowalewski T., Holtzman D.M. In situ atomic force microscopy study of Alzheimer's β-amyloid peptide on different substrates: new insights into mechanism of β-sheet formation. Proc. Natl Acad. Sci. USA. 96:1999;3688-3693.
29. LeVine H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:1993;404-410.
30. DeMattos R.B., Brendza R.P., Heuser J.E., Kierson M., Cirrito J.R., Fryer J., et al. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem. Int. 39:2001;415-425.
31. Spisz T., Fang Y., Reeves R., Seymour C., Bankman I., Hoh J. Automated sizing of DNA fragments in atomic force microscope images. Med. Biol. Eng. Comput. 36:1998;667-672.
32. Zhang T.Y., Suen C.Y. A fast parallel algorithm for thinning digital patterns. Commun. ACM. 27:1984;236-239.